National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Abasaglar® is indicated in the treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above.

Rapid Review

Commenced Completed Outcome
04/09/2015 12/10/2015 Full Pharmacoeconomic Evaluation Not Recommended